Jef Feeley
Bloomberg
Contact Jef
Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.
| Recent: |
|
| Past: |
|
Past articles by Jef:
Twitter Seeks Documents Related to Federal Investigation of Musk
Twitter Inc.’s lawyers tried again last week to learn what Elon Musk had told federal authorities who were investigating his attempt to take the social media company private. Attorneys for Twitter wrote to a Delaware judge on Oct. 6 saying they needed documents about the probes, according to a letter unsealed in court Thursday. Musk had by that point reversed himself on walking away from the $44… → Read More
Musk's Twitter Takeover Hits Snag Over Debt-Financing Issue
Talks between Elon Musk and Twitter Inc. to reach a resolution of the $44 billion takeover are stuck in part over Musk’s statement that his offer is now contingent on receiving $13 billion in debt financing, according to people familiar with the matter. → Read More
Twitter Assembles Legal Team to Sue Musk Over Dropped Takeover
Twitter Inc. has hired merger law heavyweight Wachtell, Lipton, Rosen & Katz as it races to sue Elon Musk for moving to dump his $44 billion takeover of the company, according to people familiar with the matter. → Read More
Bayer Faces Roundup Trial Featuring Ex-Monsanto CEO’s Testimony
Bayer AG faces a trial over its Roundup weedkiller in which the ex-chief executive officer of its Monsanto unit will testify for the first time as to what he knew about the product’s cancer risks. → Read More
J&J’s Controversial Prison Testing Resurfaces in Baby Powder Lawsuits
The company funded experiments on mostly Black men comparing the effects of talc and asbestos on their skin → Read More
Aerojet Chairman Sues CEO Over Control of Rocket-Engine Maker’s Board
Aerojet Rocketdyne Inc.’s chairman and three directors asked a judge to block the CEO and her allies on the board from using company resources in a fight for control of the rocket-engine maker. A lawsuit unsealed Friday revealed long-simmering tensions between Chairman Warren Lichtenstein and Chief Executive Officer Eileen Drake who are at the heart of a proxy battle launched as U.S. antitrust… → Read More
Bayer Loses Third Appeal of Roundup Herbicide Cancer Verdict
Bayer AG’s Roundup woes deepened as it lost another appeal of a jury verdict finding its weed killer causes cancer, the company’s third consecutive appeals court loss of the cases that have gone to trial.A California appeals court in San Francisco refused to overturn the 2019 verdict in which a jury awarded more than $2 billion to a couple who claimed they fell ill after using the herbicide for… → Read More
Bayer to Set Aside $4.5 Billion for Potential Roundup Claims
Bayer AG will set aside $4.5 billion in the second quarter to cover potential future exposure tied to its Roundup weedkiller. → Read More
Tesla sued for airbag malfunction in Model 3 highway crash
Tesla Inc. was sued over a Maryland highway crash last year in which a Model 3's air bags... → Read More
Rock-Star Outfitter John Varvatos’s Firm Files for Bankruptcy
John Varvatos Enterprises Inc., a men’s fashion brand favored by rock stars and celebrities such as Dave Matthews and Ben Affleck, sought bankruptcy protection from creditors as the fallout from the Covid-19 pandemic derailed a corporate comeback effort. → Read More
WeWork’s Adam Neumann Sues SoftBank Over Canceled Stock Deal
WeWork co-founder Adam Neumann sued SoftBank Group Corp., its biggest investor, over the Japanese company’s decision to scuttle a $3 billion deal to buy stock from employees and other shareholders. → Read More
J&J Denials of Asbestos in Baby Powder Spur Criminal Probe
The U.S. Justice Department is pursuing a criminal investigation into whether Johnson & Johnson lied to the public about the possible cancer risks of its talcum powder, people with knowledge of the matter said. → Read More
Anthem Says Bid to Save $49 Billion Deal Was ‘Cut Off at Knees’
Cigna Corp. officials did everything they could to sabotage a $48.9 billion merger with Anthem Inc., including refusing to consider divestitures that would have helped the deal win regulatory approval, Anthem’s general counsel told a judge. → Read More
J&J Is Willing to Pay $400 Million-Plus in Hip-Device Cases
Johnson & Johnson is willing to pay more than $400 million to settle some of the thousands of consumers’ allegations that the company sold defective artificial hips and hid the health risks of the devices, people familiar with the negotiations said. → Read More
Facebook’s Mark Zuckerberg To Testify In November In Investor Suit
(Bloomberg) -- Facebook Inc. co-founder Mark Zuckerberg is slated to appear before a judge Nov. → Read More
Facebook Directors Sued Over Handling Of Non-Voting Shares
A pension fund sued Facebook Inc. directors for being too accommodating when co-founder Mark Zuckerberg sought to create non-voting shares so he could retain control after selling most of his stake to fund his family’s philanthropic endeavors. → Read More
CBS Director Who Recorded Redstone Says He Wasn't Sneaking Shots
A CBS Corp. director accused of secretly recording Sumner Redstone says he wasn’t skulking around when he trained his iPhone on the ailing billionaire. → Read More
CBS Judge Questions Redstone's Mental State Ahead of Court Fight
The judge who will decide whether CBS Corp. directors can strip Sumner Redstone of his controlling interest in the media company has expressed concerns about the ailing billionaire’s mental capacity and his ability to participate in efforts to block the move. → Read More
Sumner Redstone Doesn't Have to Face Deposition in CBS Fight
Billionaire Sumner Redstone won’t have to face questioning from lawyers representing directors at CBS Corp. over his role in fighting their efforts to strip his family of its controlling interest in the media company. → Read More
AstraZeneca to Pay $110 Million to Settle Texas Drug Suits
AstraZeneca Plc agreed to pay $110 million to settle a Texas claim alleging that the company cheated the state’s Medicaid program by fraudulently marketing two medications, according to the state’s attorney general office. → Read More